{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:17:54Z","timestamp":1784920674852,"version":"3.55.0"},"reference-count":233,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["G-22-0031983"],"award-info":[{"award-number":["G-22-0031983"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013873","name":"Government of Ontario","doi-asserted-by":"publisher","award":["Ontario PhD Graduate Scholarship"],"award-info":[{"award-number":["Ontario PhD Graduate Scholarship"]}],"id":[{"id":"10.13039\/100013873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00109-023-02359-8","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T15:02:01Z","timestamp":1692975721000},"page":"1191-1208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Role of the pioneer transcription factor GATA2 in health and disease"],"prefix":"10.1007","volume":"101","author":[{"given":"Amena","family":"Aktar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2392-468X","authenticated-orcid":false,"given":"Bryan","family":"Heit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"issue":"41","key":"2359_CR1","doi-asserted-by":"publisher","first-page":"31087","DOI":"10.1074\/jbc.R110.159079","volume":"285","author":"EH Bresnick","year":"2010","unstructured":"Bresnick EH et al (2010) GATA switches as developmental drivers. J Biol Chem 285(41):31087\u201331093","journal-title":"J Biol Chem"},{"issue":"3","key":"2359_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.biocel.2011.12.004","volume":"44","author":"NP Rodrigues","year":"2012","unstructured":"Rodrigues NP et al (2012) GATA-2 mediated regulation of normal hematopoietic stem\/progenitor cell function, myelodysplasia and myeloid leukemia. Int J Biochem Cell Biol 44(3):457\u2013460","journal-title":"Int J Biochem Cell Biol"},{"issue":"13","key":"2359_CR3","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1096\/fj.02-0168fje","volume":"16","author":"K La Ferla","year":"2002","unstructured":"La Ferla K et al (2002) Inhibition of erythropoietin gene expression signaling involves the transcription factors GATA-2 and NF-kappaB. Faseb J 16(13):1811\u20131813","journal-title":"Faseb J"},{"issue":"12","key":"2359_CR4","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1093\/emboj\/cdf301","volume":"21","author":"K Kitajima","year":"2002","unstructured":"Kitajima K et al (2002) GATA-2 and GATA-2\/ER display opposing activities in the development and differentiation of blood progenitors. Embo J 21(12):3060\u20133069","journal-title":"Embo J"},{"issue":"15","key":"2359_CR5","doi-asserted-by":"publisher","first-page":"6824","DOI":"10.1128\/MCB.24.15.6824-6836.2004","volume":"24","author":"S Tsuzuki","year":"2004","unstructured":"Tsuzuki S et al (2004) Cross talk between retinoic acid signaling and transcription factor GATA-2. Mol Cell Biol 24(15):6824\u20136836","journal-title":"Mol Cell Biol"},{"issue":"7","key":"2359_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1084\/jem.20031556","volume":"200","author":"KW Ling","year":"2004","unstructured":"Ling KW et al (2004) GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells. J Exp Med 200(7):871\u2013882","journal-title":"J Exp Med"},{"issue":"6494","key":"2359_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/371221a0","volume":"371","author":"FY Tsai","year":"1994","unstructured":"Tsai FY et al (1994) An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371(6494):221\u2013226","journal-title":"Nature"},{"issue":"10","key":"2359_CR8","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1182\/blood.V89.10.3636","volume":"89","author":"FY Tsai","year":"1997","unstructured":"Tsai FY, Orkin SH (1997) Transcription factor GATA-2 is required for proliferation\/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 89(10):3636\u20133643","journal-title":"Blood"},{"issue":"12","key":"2359_CR9","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1182\/blood.V93.12.4196","volume":"93","author":"N Minegishi","year":"1999","unstructured":"Minegishi N et al (1999) The mouse GATA-2 gene is expressed in the para-aortic splanchnopleura and aorta-gonads and mesonephros region. Blood 93(12):4196\u20134207","journal-title":"Blood"},{"issue":"2","key":"2359_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/dbio.1999.9278","volume":"210","author":"J Nardelli","year":"1999","unstructured":"Nardelli J et al (1999) Expression and genetic interaction of transcription factors GATA-2 and GATA-3 during development of the mouse central nervous system. Dev Biol 210(2):305\u2013321","journal-title":"Dev Biol"},{"issue":"11","key":"2359_CR11","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1242\/dev.120.11.3257","volume":"120","author":"YK Ng","year":"1994","unstructured":"Ng YK et al (1994) GATA factor activity is required for the trophoblast-specific transcriptional regulation of the mouse placental lactogen I gene. Development 120(11):3257\u20133266","journal-title":"Development"},{"key":"2359_CR12","doi-asserted-by":"crossref","unstructured":"Dorfman DM et al (1992) Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells. J Biol Chem 267(2):1279\u20131285","DOI":"10.1016\/S0021-9258(18)48426-8"},{"issue":"1\u20132","key":"2359_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/0169-328X(94)90216-X","volume":"23","author":"JM Kornhauser","year":"1994","unstructured":"Kornhauser JM et al (1994) Temporal and spatial changes in GATA transcription factor expression are coincident with development of the chicken optic tectum. Brain Res Mol Brain Res 23(1\u20132):100\u2013110","journal-title":"Brain Res Mol Brain Res"},{"issue":"10","key":"2359_CR14","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1172\/JCI61619","volume":"122","author":"KC Lim","year":"2012","unstructured":"Lim KC et al (2012) Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning. J Clin Invest 122(10):3705\u20133717","journal-title":"J Clin Invest"},{"issue":"17","key":"2359_CR15","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1242\/dev.127.17.3829","volume":"127","author":"Y Zhou","year":"2000","unstructured":"Zhou Y, Yamamoto M, Engel JD (2000) GATA2 is required for the generation of V2 interneurons. Development 127(17):3829\u20133838","journal-title":"Development"},{"key":"2359_CR16","doi-asserted-by":"crossref","unstructured":"Tremblay M, Sanchez-Ferras O, and Bouchard M (2018) GATA transcription factors in development and disease. Development 145(20)","DOI":"10.1242\/dev.164384"},{"issue":"24","key":"2359_CR17","doi-asserted-by":"publisher","first-page":"16188","DOI":"10.1016\/S0021-9258(18)98533-9","volume":"266","author":"ME Lee","year":"1991","unstructured":"Lee ME et al (1991) Cloning of the GATA-binding protein that regulates endothelin-1 gene expression in endothelial cells. J Biol Chem 266(24):16188\u201316192","journal-title":"J Biol Chem"},{"issue":"16","key":"2359_CR18","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.1128\/MCB.25.16.7005-7020.2005","volume":"25","author":"M Kobayashi-Osaki","year":"2005","unstructured":"Kobayashi-Osaki M et al (2005) GATA motifs regulate early hematopoietic lineage-specific expression of the Gata2 gene. Mol Cell Biol 25(16):7005\u20137020","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2359_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0378-1119(96)00355-1","volume":"179","author":"DE Fleenor","year":"1996","unstructured":"Fleenor DE et al (1996) Comparison of human and Xenopus GATA-2 promoters. Gene 179(2):219\u2013223","journal-title":"Gene"},{"issue":"6","key":"2359_CR20","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1074\/jbc.273.6.3625","volume":"273","author":"N Minegishi","year":"1998","unstructured":"Minegishi N et al (1998) Alternative promoters regulate transcription of the mouse GATA-2 gene. J Biol Chem 273(6):3625\u20133634","journal-title":"J Biol Chem"},{"issue":"1","key":"2359_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/oxfordjournals.jbchem.a022570","volume":"127","author":"X Pan","year":"2000","unstructured":"Pan X et al (2000) Identification of human GATA-2 gene distal IS exon and its expression in hematopoietic stem cell fractions. J Biochem 127(1):105\u2013112","journal-title":"J Biochem"},{"issue":"2","key":"2359_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.tibs.2016.08.008","volume":"42","author":"ML Tress","year":"2017","unstructured":"Tress ML, Abascal F, Valencia A (2017) Alternative splicing may not be the key to proteome complexity. Trends Biochem Sci 42(2):98\u2013110","journal-title":"Trends Biochem Sci"},{"key":"2359_CR23","doi-asserted-by":"crossref","unstructured":"Shen C et al (2016) The PU.1-Modulated MicroRNA-22 Is a regulator of monocyte\/macrophage differentiation and acute myeloid leukemia. PLoS Genet 12(9):e1006259","DOI":"10.1371\/journal.pgen.1006259"},{"issue":"1","key":"2359_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2011.04.007","volume":"82","author":"C Vicente","year":"2012","unstructured":"Vicente C et al (2012) The role of the GATA2 transcription factor in normal and malignant hematopoiesis. Crit Rev Oncol Hematol 82(1):1\u201317","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"2359_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1101\/gr.212092.116","volume":"27","author":"F Inoue","year":"2017","unstructured":"Inoue F et al (2017) A systematic comparison reveals substantial differences in chromosomal versus episomal encoding of enhancer activity. Genome Res 27(1):38\u201352","journal-title":"Genome Res"},{"issue":"7","key":"2359_CR26","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/sj.cdd.4401811","volume":"13","author":"V Lulli","year":"2006","unstructured":"Lulli V et al (2006) Overexpression of Ets-1 in human hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiation. Cell Death Differ 13(7):1064\u20131074","journal-title":"Cell Death Differ"},{"issue":"6","key":"2359_CR27","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1182\/blood.V88.6.1965.bloodjournal8861965","volume":"88","author":"M Maeno","year":"1996","unstructured":"Maeno M et al (1996) The role of BMP-4 and GATA-2 in the induction and differentiation of hematopoietic mesoderm in Xenopus laevis. Blood 88(6):1965\u20131972","journal-title":"Blood"},{"issue":"5","key":"2359_CR28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1242\/dev.01660","volume":"132","author":"A Robert-Moreno","year":"2005","unstructured":"Robert-Moreno A et al (2005) RBPjkappa-dependent Notch function regulates Gata2 and is essential for the formation of intra-embryonic hematopoietic cells. Development 132(5):1117\u20131126","journal-title":"Development"},{"issue":"12","key":"2359_CR29","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1182\/blood.V98.12.3283","volume":"98","author":"K Kumano","year":"2001","unstructured":"Kumano K et al (2001) Notch1 inhibits differentiation of hematopoietic cells by sustaining GATA-2 expression. Blood 98(12):3283\u20133289","journal-title":"Blood"},{"key":"2359_CR30","doi-asserted-by":"crossref","unstructured":"Walsh JC et al (2002) Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. Immunity 17(5):665\u2013676","DOI":"10.1016\/S1074-7613(02)00452-1"},{"issue":"35","key":"2359_CR31","doi-asserted-by":"publisher","first-page":"30712","DOI":"10.1074\/jbc.M504293200","volume":"280","author":"B Yatsula","year":"2005","unstructured":"Yatsula B et al (2005) Identification of binding sites of EVI1 in mammalian cells. J Biol Chem 280(35):30712\u201330722","journal-title":"J Biol Chem"},{"issue":"11","key":"2359_CR32","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1038\/sj.emboj.7600679","volume":"24","author":"H Yuasa","year":"2005","unstructured":"Yuasa H et al (2005) Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression. EMBO J 24(11):1976\u20131987","journal-title":"EMBO J"},{"issue":"9","key":"2359_CR33","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1242\/dev.001297","volume":"134","author":"M Khandekar","year":"2007","unstructured":"Khandekar M et al (2007) A Gata2 intronic enhancer confers its pan-endothelia-specific regulation. Development 134(9):1703\u20131712","journal-title":"Development"},{"issue":"13","key":"2359_CR34","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1084\/jem.20130733","volume":"210","author":"X Gao","year":"2013","unstructured":"Gao X et al (2013) Gata2 cis-element is required for hematopoietic stem cell generation in the mammalian embryo. J Exp Med 210(13):2833\u20132842","journal-title":"J Exp Med"},{"issue":"3","key":"2359_CR35","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1172\/JCI122694","volume":"129","author":"AA Soukup","year":"2019","unstructured":"Soukup AA et al (2019) Single-nucleotide human disease mutation inactivates a blood-regenerative GATA2 enhancer. J Clin Invest 129(3):1180\u20131192","journal-title":"J Clin Invest"},{"issue":"3","key":"2359_CR36","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1074\/jbc.M406038200","volume":"280","author":"ML Martowicz","year":"2005","unstructured":"Martowicz ML et al (2005) Dynamic GATA factor interplay at a multicomponent regulatory region of the GATA-2 locus. J Biol Chem 280(3):1724\u20131732","journal-title":"J Biol Chem"},{"issue":"19","key":"2359_CR37","doi-asserted-by":"publisher","first-page":"7056","DOI":"10.1128\/MCB.01033-06","volume":"26","author":"JA Grass","year":"2006","unstructured":"Grass JA et al (2006) Distinct functions of dispersed GATA factor complexes at an endogenous gene locus. Mol Cell Biol 26(19):7056\u20137067","journal-title":"Mol Cell Biol"},{"issue":"14","key":"2359_CR38","doi-asserted-by":"publisher","first-page":"8976","DOI":"10.1074\/jbc.M709364200","volume":"283","author":"W Brandt","year":"2008","unstructured":"Brandt W et al (2008) Defining the functional boundaries of the Gata2 locus by rescue with a linked bacterial artificial chromosome transgene. J Biol Chem 283(14):8976\u20138983","journal-title":"J Biol Chem"},{"issue":"12","key":"2359_CR39","doi-asserted-by":"publisher","first-page":"E1091","DOI":"10.1073\/pnas.1400065111","volume":"111","author":"R Sanalkumar","year":"2014","unstructured":"Sanalkumar R et al (2014) Mechanism governing a stem cell-generating cis-regulatory element. Proc Natl Acad Sci USA 111(12):E1091\u2013E1100","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2359_CR40","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1073\/pnas.94.12.6267","volume":"94","author":"A Meng","year":"1997","unstructured":"Meng A et al (1997) Promoter analysis in living zebrafish embryos identifies a cis-acting motif required for neuronal expression of GATA-2. Proc Natl Acad Sci USA 94(12):6267\u20136272","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2359_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227646","volume":"15","author":"N Hirahara","year":"2020","unstructured":"Hirahara N et al (2020) Liganded T3 receptor beta2 inhibits the positive feedback autoregulation of the gene for GATA2, a transcription factor critical for thyrotropin production. PLoS ONE 15(1):e0227646","journal-title":"PLoS ONE"},{"issue":"15","key":"2359_CR42","doi-asserted-by":"publisher","first-page":"8811","DOI":"10.1073\/pnas.1432147100","volume":"100","author":"JA Grass","year":"2003","unstructured":"Grass JA et al (2003) GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling. Proc Natl Acad Sci USA 100(15):8811\u20138816","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2359_CR43","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/leu.2014.67","volume":"28","author":"M Celton","year":"2014","unstructured":"Celton M et al (2014) Epigenetic regulation of GATA2 and its impact on normal karyotype acute myeloid leukemia. Leukemia 28(8):1617\u20131626","journal-title":"Leukemia"},{"issue":"1","key":"2359_CR44","first-page":"21","volume":"2","author":"K Niimi","year":"2013","unstructured":"Niimi K et al (2013) GATA2 zinc finger 2 mutation found in acute myeloid leukemia impairs myeloid differentiation. Leuk Res Rep 2(1):21\u201325","journal-title":"Leuk Res Rep"},{"key":"2359_CR45","doi-asserted-by":"crossref","unstructured":"Zhang P et al (1999) Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proc Natl Acad Sci USA\u00a0 96(15):8705\u201310","DOI":"10.1073\/pnas.96.15.8705"},{"issue":"14","key":"2359_CR46","doi-asserted-by":"publisher","first-page":"9237","DOI":"10.1073\/pnas.142302099","volume":"99","author":"AN Chang","year":"2002","unstructured":"Chang AN et al (2002) GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis. Proc Natl Acad Sci USA 99(14):9237\u20139242","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2359_CR47","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1161\/01.RES.0000076893.70898.36","volume":"92","author":"TH Chun","year":"2003","unstructured":"Chun TH et al (2003) Modification of GATA-2 transcriptional activity in endothelial cells by the SUMO E3 ligase PIASy. Circ Res 92(11):1201\u20131208","journal-title":"Circ Res"},{"issue":"7","key":"2359_CR48","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1182\/blood.V98.7.2116","volume":"98","author":"Y Ozawa","year":"2001","unstructured":"Ozawa Y et al (2001) Histone deacetylase 3 associates with and represses the transcription factor GATA-2. Blood 98(7):2116\u20132123","journal-title":"Blood"},{"issue":"9","key":"2359_CR49","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1182\/blood.V99.9.3404","volume":"99","author":"S Tsuzuki","year":"2002","unstructured":"Tsuzuki S, Enver T (2002) Interactions of GATA-2 with the promyelocytic leukemia zinc finger (PLZF) protein, its homologue FAZF, and the t(11;17)-generated PLZF-retinoic acid receptor alpha oncoprotein. Blood 99(9):3404\u20133410","journal-title":"Blood"},{"issue":"5489","key":"2359_CR50","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1126\/science.290.5489.134","volume":"290","author":"Q Tong","year":"2000","unstructured":"Tong Q et al (2000) Function of GATA transcription factors in preadipocyte-adipocyte transition. Science 290(5489):134\u2013138","journal-title":"Science"},{"issue":"2","key":"2359_CR51","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1128\/MCB.25.2.706-715.2005","volume":"25","author":"Q Tong","year":"2005","unstructured":"Tong Q et al (2005) Interaction between GATA and the C\/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation. Mol Cell Biol 25(2):706\u2013715","journal-title":"Mol Cell Biol"},{"issue":"10","key":"2359_CR52","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1182\/blood-2011-12-397083","volume":"120","author":"M Luesink","year":"2012","unstructured":"Luesink M et al (2012) High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia. Blood 120(10):2064\u20132075","journal-title":"Blood"},{"key":"2359_CR53","doi-asserted-by":"crossref","unstructured":"Leubolt G, Redondo Monte\u00a0E, and Greif\u00a0PA (2020) GATA2 mutations in myeloid malignancies: Two zinc fingers in many pies. IUBMB Life 72(1):151\u2013158","DOI":"10.1002\/iub.2204"},{"issue":"10","key":"2359_CR54","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","volume":"118","author":"AP Hsu","year":"2011","unstructured":"Hsu AP et al (2011) Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118(10):2653\u20132655","journal-title":"Blood"},{"issue":"2","key":"2359_CR55","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1128\/MCB.15.2.634","volume":"15","author":"JE Visvader","year":"1995","unstructured":"Visvader JE et al (1995) The C-terminal zinc finger of GATA-1 or GATA-2 is sufficient to induce megakaryocytic differentiation of an early myeloid cell line. Mol Cell Biol 15(2):634\u2013641","journal-title":"Mol Cell Biol"},{"key":"2359_CR56","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/1471-2105-10-202","volume":"10","author":"AN Nguyen Ba","year":"2009","unstructured":"Nguyen Ba AN et al (2009) NLStradamus: a simple Hidden Markov Model for nuclear localization signal prediction. BMC Bioinformatics 10:202","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"2359_CR57","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1083\/jcb.107.3.841","volume":"107","author":"C Dingwall","year":"1988","unstructured":"Dingwall C et al (1988) The nucleoplasmin nuclear location sequence is larger and more complex than that of SV-40 large T antigen. J Cell Biol 107(3):841\u2013849","journal-title":"J Cell Biol"},{"issue":"3","key":"2359_CR58","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1182\/blood-2002-12-3809","volume":"102","author":"N Minegishi","year":"2003","unstructured":"Minegishi N et al (2003) Expression and domain-specific function of GATA-2 during differentiation of the hematopoietic precursor cells in midgestation mouse embryos. Blood 102(3):896\u2013905","journal-title":"Blood"},{"issue":"4","key":"2359_CR59","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1210\/me.2007-0513","volume":"22","author":"RS Viger","year":"2008","unstructured":"Viger RS et al (2008) Role of the GATA family of transcription factors in endocrine development, function, and disease. Mol Endocrinol 22(4):781\u2013798","journal-title":"Mol Endocrinol"},{"issue":"3","key":"2359_CR60","first-page":"2201","volume":"14","author":"Z Yang","year":"1994","unstructured":"Yang Z et al (1994) Human GATA-3 trans-activation, DNA-binding, and nuclear localization activities are organized into distinct structural domains. Mol Cell Biol 14(3):2201\u20132212","journal-title":"Mol Cell Biol"},{"issue":"9","key":"2359_CR61","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/gtc.12628","volume":"23","author":"K Kitajima","year":"2018","unstructured":"Kitajima K et al (2018) Domain-specific biological functions of the transcription factor Gata2 on hematopoietic differentiation of mouse embryonic stem cells. Genes Cells 23(9):753\u2013766","journal-title":"Genes Cells"},{"issue":"5","key":"2359_CR62","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.jmb.2008.06.072","volume":"381","author":"DL Bates","year":"2008","unstructured":"Bates DL et al (2008) Crystal structures of multiple GATA zinc fingers bound to DNA reveal new insights into DNA recognition and self-association by GATA. J Mol Biol 381(5):1292\u20131306","journal-title":"J Mol Biol"},{"issue":"7","key":"2359_CR63","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1365-2443.2005.00864.x","volume":"10","author":"N Minegishi","year":"2005","unstructured":"Minegishi N et al (2005) Rapid turnover of GATA-2 via ubiquitin-proteasome protein degradation pathway. Genes Cells 10(7):693\u2013704","journal-title":"Genes Cells"},{"issue":"8","key":"2359_CR64","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1074\/jbc.270.8.4101","volume":"270","author":"M Towatari","year":"1995","unstructured":"Towatari M et al (1995) Regulation of GATA-2 phosphorylation by mitogen-activated protein kinase and interleukin-3. J Biol Chem 270(8):4101\u20134107","journal-title":"J Biol Chem"},{"issue":"3","key":"2359_CR65","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1189\/jlb.0603389","volume":"75","author":"F Hayakawa","year":"2004","unstructured":"Hayakawa F et al (2004) Functional regulation of GATA-2 by acetylation. J Leukoc Biol 75(3):529\u2013540","journal-title":"J Leukoc Biol"},{"issue":"6","key":"2359_CR66","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/0955-0674(93)90090-D","volume":"5","author":"AD Whetton","year":"1993","unstructured":"Whetton AD, Dexter TM (1993) Influence of growth factors and substrates on differentiation of haemopoietic stem cells. Curr Opin Cell Biol 5(6):1044\u20131049","journal-title":"Curr Opin Cell Biol"},{"issue":"7","key":"2359_CR67","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1182\/blood.V82.7.1960.1960","volume":"82","author":"A Miyajima","year":"1993","unstructured":"Miyajima A et al (1993) Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82(7):1960\u20131974","journal-title":"Blood"},{"issue":"15","key":"2359_CR68","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1161\/01.CIR.0000161814.02942.B2","volume":"111","author":"R Menghini","year":"2005","unstructured":"Menghini R et al (2005) Phosphorylation of GATA2 by Akt increases adipose tissue differentiation and reduces adipose tissue-related inflammation: a novel pathway linking obesity to atherosclerosis. Circulation 111(15):1946\u20131953","journal-title":"Circulation"},{"issue":"10","key":"2359_CR69","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1182\/blood-2006-08-044149","volume":"109","author":"S Koga","year":"2007","unstructured":"Koga S et al (2007) Cell-cycle-dependent oscillation of GATA2 expression in hematopoietic cells. Blood 109(10):4200\u20134208","journal-title":"Blood"},{"issue":"2","key":"2359_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001290","volume":"7","author":"T Kaplan","year":"2011","unstructured":"Kaplan T et al (2011) Quantitative models of the mechanisms that control genome-wide patterns of transcription factor binding during early Drosophila development. PLoS Genet 7(2):e1001290","journal-title":"PLoS Genet"},{"issue":"24","key":"2359_CR71","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1101\/gad.253443.114","volume":"28","author":"M Iwafuchi-Doi","year":"2014","unstructured":"Iwafuchi-Doi M, Zaret KS (2014) Pioneer transcription factors in cell reprogramming. Genes Dev 28(24):2679\u20132692","journal-title":"Genes Dev"},{"issue":"21","key":"2359_CR72","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1101\/gad.176826.111","volume":"25","author":"KS Zaret","year":"2011","unstructured":"Zaret KS, Carroll JS (2011) Pioneer transcription factors: establishing competence for gene expression. Genes Dev 25(21):2227\u20132241","journal-title":"Genes Dev"},{"key":"2359_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.626383","volume":"8","author":"Y Ye","year":"2020","unstructured":"Ye Y, Chen X, Zhang W (2020) Mammalian SWI\/SNF chromatin remodeling complexes in embryonic stem cells: regulating the balance between pluripotency and differentiation. Front Cell Dev Biol 8:626383","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"2359_CR74","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1093\/nar\/gkt1382","volume":"42","author":"D Wu","year":"2014","unstructured":"Wu D et al (2014) Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer. Nucleic Acids Res 42(6):3607\u20133622","journal-title":"Nucleic Acids Res"},{"key":"2359_CR75","doi-asserted-by":"crossref","unstructured":"Jung MM et al (2023) Pathogenic human variant that dislocates GATA2 zinc fingers disrupts hematopoietic gene expression and signaling networks. J Clin Invest 133(7)","DOI":"10.1172\/JCI162685"},{"issue":"16","key":"2359_CR76","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1182\/blood-2011-09-380634","volume":"119","author":"LC Dore","year":"2012","unstructured":"Dore LC et al (2012) Chromatin occupancy analysis reveals genome-wide GATA factor switching during hematopoiesis. Blood 119(16):3724\u20133733","journal-title":"Blood"},{"issue":"14","key":"2359_CR77","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1182\/blood-2013-03-490425","volume":"122","author":"D Beck","year":"2013","unstructured":"Beck D et al (2013) Genome-wide analysis of transcriptional regulators in human HSPCs reveals a densely interconnected network of coding and noncoding genes. Blood 122(14):e12-22","journal-title":"Blood"},{"issue":"6","key":"2359_CR78","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.stem.2013.09.003","volume":"13","author":"G May","year":"2013","unstructured":"May G et al (2013) Dynamic analysis of gene expression and genome-wide transcription factor binding during lineage specification of multipotent progenitors. Cell Stem Cell 13(6):754\u2013768","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2359_CR79","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.stem.2010.07.016","volume":"7","author":"NK Wilson","year":"2010","unstructured":"Wilson NK et al (2010) Combinatorial transcriptional control in blood stem\/progenitor cells: genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell 7(4):532\u2013544","journal-title":"Cell Stem Cell"},{"issue":"12","key":"2359_CR80","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1182\/blood-2013-12-544494","volume":"123","author":"VR Paralkar","year":"2014","unstructured":"Paralkar VR et al (2014) Lineage and species-specific long noncoding RNAs during erythro-megakaryocytic development. Blood 123(12):1927\u20131937","journal-title":"Blood"},{"issue":"5","key":"2359_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.103029","volume":"299","author":"HSJ Man","year":"2023","unstructured":"Man HSJ et al (2023) Long noncoding RNA GATA2-AS1 augments endothelial hypoxia inducible factor 1-alpha induction and regulates hypoxic signaling. J Biol Chem 299(5):103029","journal-title":"J Biol Chem"},{"key":"2359_CR82","doi-asserted-by":"crossref","unstructured":"Froese N et al (2022) Endothelial cell GATA2 modulates the cardiomyocyte stress response through the regulation of two long non-coding RNAs. Biology (Basel) 11(12)","DOI":"10.3390\/biology11121736"},{"issue":"12","key":"2359_CR83","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1182\/blood-2008-06-161117","volume":"113","author":"AJ Tipping","year":"2009","unstructured":"Tipping AJ et al (2009) High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle. Blood 113(12):2661\u20132672","journal-title":"Blood"},{"issue":"16","key":"2359_CR84","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1182\/blood.2020009707","volume":"138","author":"JAI Thoms","year":"2021","unstructured":"Thoms JAI et al (2021) Disruption of a GATA2-TAL1-ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells. Blood 138(16):1441\u20131455","journal-title":"Blood"},{"issue":"13","key":"2359_CR85","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1038\/sj.emboj.7600703","volume":"24","author":"W Hong","year":"2005","unstructured":"Hong W et al (2005) FOG-1 recruits the NuRD repressor complex to mediate transcriptional repression by GATA-1. EMBO J 24(13):2367\u20132378","journal-title":"EMBO J"},{"issue":"6224","key":"2359_CR86","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/339446a0","volume":"339","author":"SF Tsai","year":"1989","unstructured":"Tsai SF et al (1989) Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature 339(6224):446\u2013451","journal-title":"Nature"},{"issue":"3","key":"2359_CR87","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1084\/jem.20070544","volume":"205","author":"AB Cantor","year":"2008","unstructured":"Cantor AB et al (2008) Antagonism of FOG-1 and GATA factors in fate choice for the mast cell lineage. J Exp Med 205(3):611\u2013624","journal-title":"J Exp Med"},{"issue":"2","key":"2359_CR88","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0378-1119(00)00510-2","volume":"261","author":"P Ikonomi","year":"2000","unstructured":"Ikonomi P et al (2000) Levels of GATA-1\/GATA-2 transcription factors modulate expression of embryonic and fetal hemoglobins. Gene 261(2):277\u2013287","journal-title":"Gene"},{"issue":"3","key":"2359_CR89","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1182\/blood.V96.3.910","volume":"96","author":"S Takahashi","year":"2000","unstructured":"Takahashi S et al (2000) GATA factor transgenes under GATA-1 locus control rescue germline GATA-1 mutant deficiencies. Blood 96(3):910\u2013916","journal-title":"Blood"},{"issue":"1","key":"2359_CR90","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.devcel.2015.12.014","volume":"36","author":"J Huang","year":"2016","unstructured":"Huang J et al (2016) Dynamic control of enhancer repertoires drives lineage and stage-specific transcription during hematopoiesis. Dev Cell 36(1):9\u201323","journal-title":"Dev Cell"},{"key":"2359_CR91","doi-asserted-by":"crossref","unstructured":"Gillespie MA et al (2020) Absolute quantification of transcription factors reveals principles of gene regulation in erythropoiesis. Mol Cell 78(5):960\u2013974e11","DOI":"10.1016\/j.molcel.2020.03.031"},{"issue":"13","key":"2359_CR92","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1093\/nar\/gks281","volume":"40","author":"EH Bresnick","year":"2012","unstructured":"Bresnick EH et al (2012) Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies. Nucleic Acids Res 40(13):5819\u20135831","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"2359_CR93","doi-asserted-by":"publisher","first-page":"12355","DOI":"10.1073\/pnas.93.22.12355","volume":"93","author":"Y Fujiwara","year":"1996","unstructured":"Fujiwara Y et al (1996) Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc Natl Acad Sci USA 93(22):12355\u201312358","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2359_CR94","doi-asserted-by":"publisher","first-page":"4601","DOI":"10.1073\/pnas.92.10.4601","volume":"92","author":"D Orlic","year":"1995","unstructured":"Orlic D et al (1995) Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. Proc Natl Acad Sci USA 92(10):4601\u20134605","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2359_CR95","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1073\/pnas.0711824105","volume":"105","author":"SJ Zhang","year":"2008","unstructured":"Zhang SJ et al (2008) Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc Natl Acad Sci USA 105(6):2076\u20132081","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2359_CR96","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1182\/blood-2002-04-1177","volume":"100","author":"S Ezoe","year":"2002","unstructured":"Ezoe S et al (2002) GATA-2\/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21(WAF1) and p27(Kip1) proteins. Blood 100(10):3512\u20133520","journal-title":"Blood"},{"issue":"13","key":"2359_CR97","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1084\/jem.20130751","volume":"210","author":"E de Pater","year":"2013","unstructured":"de Pater E et al (2013) Gata2 is required for HSC generation and survival. J Exp Med 210(13):2843\u20132850","journal-title":"J Exp Med"},{"issue":"5","key":"2359_CR98","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1182\/blood-2012-08-447367","volume":"121","author":"M Pasquet","year":"2013","unstructured":"Pasquet M et al (2013) High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood 121(5):822\u2013829","journal-title":"Blood"},{"issue":"2","key":"2359_CR99","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1182\/blood.V93.2.488","volume":"93","author":"DA Persons","year":"1999","unstructured":"Persons DA et al (1999) Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis. Blood 93(2):488\u2013499","journal-title":"Blood"},{"issue":"2","key":"2359_CR100","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1182\/blood-2004-08-2989","volume":"106","author":"NP Rodrigues","year":"2005","unstructured":"Rodrigues NP et al (2005) Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. Blood 106(2):477\u2013484","journal-title":"Blood"},{"key":"2359_CR101","doi-asserted-by":"crossref","unstructured":"Bruzzese A et al (2020) GATA2 Related conditions and predisposition to pediatric myelodysplastic syndromes. Cancers (Basel) 12(10)","DOI":"10.3390\/cancers12102962"},{"issue":"1","key":"2359_CR102","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/ACI.0000000000000126","volume":"15","author":"AP Hsu","year":"2015","unstructured":"Hsu AP, McReynolds LJ, Holland SM (2015) GATA2 deficiency. Curr Opin Allergy Clin Immunol 15(1):104\u2013109","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"10","key":"2359_CR103","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/ng.923","volume":"43","author":"P Ostergaard","year":"2011","unstructured":"Ostergaard P et al (2011) Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet 43(10):929\u2013931","journal-title":"Nat Genet"},{"issue":"13","key":"2359_CR104","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1182\/bloodadvances.2019000378","volume":"3","author":"EH Bresnick","year":"2019","unstructured":"Bresnick EH, Johnson KD (2019) Blood disease-causing and -suppressing transcriptional enhancers: general principles and GATA2 mechanisms. Blood Adv 3(13):2045\u20132056","journal-title":"Blood Adv"},{"issue":"8","key":"2359_CR105","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1182\/blood-2009-03-208629","volume":"115","author":"DC Vinh","year":"2010","unstructured":"Vinh DC et al (2010) Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood 115(8):1519\u20131529","journal-title":"Blood"},{"issue":"10","key":"2359_CR106","first-page":"2656","volume":"118","author":"RE Dickinson","year":"2011","unstructured":"Dickinson RE et al (2011) Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte. B and NK lymphoid deficiency Blood 118(10):2656\u20132658","journal-title":"B and NK lymphoid deficiency Blood"},{"issue":"10","key":"2359_CR107","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/ng.913","volume":"43","author":"CN Hahn","year":"2011","unstructured":"Hahn CN et al (2011) Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet 43(10):1012\u20131017","journal-title":"Nat Genet"},{"issue":"14","key":"2359_CR108","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1182\/blood-2012-09-453969","volume":"121","author":"EM Mace","year":"2013","unstructured":"Mace EM et al (2013) Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset. Blood 121(14):2669\u20132677","journal-title":"Blood"},{"key":"2359_CR109","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3389\/fimmu.2016.00545","volume":"7","author":"EM Mace","year":"2016","unstructured":"Mace EM, Orange JS (2016) Genetic causes of human NK cell deficiency and their effect on NK cell subsets. Front Immunol 7:545","journal-title":"Front Immunol"},{"issue":"3","key":"2359_CR110","first-page":"79","volume":"41","author":"P Cascone","year":"1992","unstructured":"Cascone P et al (1992) Neuromuscular assessment and postural examination in patients with TMJ condylo-meniscal incoordination. Minerva Stomatol 41(3):79\u201390","journal-title":"Minerva Stomatol"},{"issue":"2","key":"2359_CR111","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1084\/jem.20101459","volume":"208","author":"V Bigley","year":"2011","unstructured":"Bigley V et al (2011) The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med 208(2):227\u2013234","journal-title":"J Exp Med"},{"issue":"1","key":"2359_CR112","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/leu.2016.256","volume":"31","author":"LW Ding","year":"2017","unstructured":"Ding LW et al (2017) Mutational profiling of a MonoMAC syndrome family with GATA2 deficiency. Leukemia 31(1):244\u2013245","journal-title":"Leukemia"},{"issue":"5","key":"2359_CR113","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/cid\/cit368","volume":"57","author":"JF Camargo","year":"2013","unstructured":"Camargo JF et al (2013) MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature. Clin Infect Dis 57(5):697\u2013699","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2359_CR114","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00431-012-1715-7","volume":"171","author":"H Ishida","year":"2012","unstructured":"Ishida H et al (2012) GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia. Eur J Pediatr 171(8):1273\u20131276","journal-title":"Eur J Pediatr"},{"key":"2359_CR115","doi-asserted-by":"crossref","unstructured":"Portich JP, Condino Neto\u00a0A, Faulhaber\u00a0GAM (2020) Humoral deficiency in a novel GATA2 mutation: a new clinical presentation successfully treated with hematopoietic stem cell transplantation. Pediatr Blood Cancer 67(9):e28374","DOI":"10.1002\/pbc.28374"},{"issue":"1","key":"2359_CR116","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12881-019-0799-6","volume":"20","author":"DP Mendes-de-Almeida","year":"2019","unstructured":"Mendes-de-Almeida DP et al (2019) GATA2 mutation in long stand Mycobacterium kansasii infection, myelodysplasia and MonoMAC syndrome: a case-report. BMC Med Genet 20(1):64","journal-title":"BMC Med Genet"},{"issue":"10","key":"2359_CR117","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s00277-018-3388-4","volume":"97","author":"A Simonis","year":"2018","unstructured":"Simonis A et al (2018) Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literature. Ann Hematol 97(10):1961\u20131973","journal-title":"Ann Hematol"},{"issue":"7","key":"2359_CR118","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s10875-018-0551-6","volume":"38","author":"L Damian","year":"2018","unstructured":"Damian L et al (2018) Pseudo-sarcoidosis revealing MonoMAC syndrome. J Clin Immunol 38(7):739\u2013741","journal-title":"J Clin Immunol"},{"issue":"4","key":"2359_CR119","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10875-018-0512-0","volume":"38","author":"I Sologuren","year":"2018","unstructured":"Sologuren I et al (2018) Lethal influenza in two related adults with inherited GATA2 deficiency. J Clin Immunol 38(4):513\u2013526","journal-title":"J Clin Immunol"},{"issue":"3","key":"2359_CR120","first-page":"315","volume":"59","author":"H Yamamoto","year":"2018","unstructured":"Yamamoto H et al (2018) MonoMAC syndrome patient developing myelodysplastic syndrome following persistent EBV infection. Rinsho Ketsueki 59(3):315\u2013322","journal-title":"Rinsho Ketsueki"},{"issue":"7","key":"2359_CR121","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27017","volume":"65","author":"K Eguchi","year":"2018","unstructured":"Eguchi K et al (2018) Nontuberculous mycobacteria-associated hemophagocytic lymphohistiocytosis in MonoMAC syndrome. Pediatr Blood Cancer 65(7):e27017","journal-title":"Pediatr Blood Cancer"},{"key":"2359_CR122","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijid.2016.11.408","volume":"54","author":"A Vila","year":"2017","unstructured":"Vila A et al (2017) Multiple opportunistic infections in a woman with GATA2 mutation. Int J Infect Dis 54:89\u201391","journal-title":"Int J Infect Dis"},{"issue":"1","key":"2359_CR123","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1182\/blood-2014-06-580340","volume":"125","author":"KA Ganapathi","year":"2015","unstructured":"Ganapathi KA et al (2015) GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. Blood 125(1):56\u201370","journal-title":"Blood"},{"issue":"8","key":"2359_CR124","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.3324\/haematol.2017.181909","volume":"103","author":"J Donadieu","year":"2018","unstructured":"Donadieu J et al (2018) Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients. Haematologica 103(8):1278\u20131287","journal-title":"Haematologica"},{"issue":"11","key":"2359_CR125","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/humu.24271","volume":"42","author":"CC Homan","year":"2021","unstructured":"Homan CC et al (2021) GATA2 deficiency syndrome: a decade of discovery. Hum Mutat 42(11):1399\u20131421","journal-title":"Hum Mutat"},{"key":"2359_CR126","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.2147\/IDR.S305825","volume":"14","author":"Y Shen","year":"2021","unstructured":"Shen Y et al (2021) Diagnosing MonoMAC syndrome in GATA2 germline mutated myelodysplastic syndrome via next-generation sequencing in a patient with refractory and complex infection: case report and literature review. Infect Drug Resist 14:1311\u20131317","journal-title":"Infect Drug Resist"},{"issue":"13","key":"2359_CR127","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1182\/blood-2011-06-365049","volume":"118","author":"J Cuellar-Rodriguez","year":"2011","unstructured":"Cuellar-Rodriguez J et al (2011) Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Blood 118(13):3715\u20133720","journal-title":"Blood"},{"key":"2359_CR128","doi-asserted-by":"crossref","unstructured":"Chu VH et al (2012) MonoMAC versus idiopathic CD4+ lymphocytopenia. Comment to Haematologica. 2011;96(8):1221\u20135. Haematologica 97(4):e9\u201311; author reply e12","DOI":"10.3324\/haematol.2011.058669"},{"issue":"4","key":"2359_CR129","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10552-007-9097-2","volume":"19","author":"JF Yamamoto","year":"2008","unstructured":"Yamamoto JF, Goodman MT (2008) Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997\u20132002. Cancer Causes Control 19(4):379\u2013390","journal-title":"Cancer Causes Control"},{"issue":"7","key":"2359_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.50","volume":"6","author":"I De Kouchkovsky","year":"2016","unstructured":"De Kouchkovsky I, Abdul-Hay M (2016) Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J 6(7):e441","journal-title":"Blood Cancer J"},{"issue":"4","key":"2359_CR131","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.beha.2012.10.004","volume":"25","author":"D Grimwade","year":"2012","unstructured":"Grimwade D (2012) The changing paradigm of prognostic factors in acute myeloid leukaemia. Best Pract Res Clin Haematol 25(4):419\u2013425","journal-title":"Best Pract Res Clin Haematol"},{"issue":"12","key":"2359_CR132","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/gcc.22756","volume":"58","author":"L Hartmann","year":"2019","unstructured":"Hartmann L, Metzeler KH (2019) Clonal hematopoiesis and preleukemia-genetics, biology, and clinical implications. Genes Chromosomes Cancer 58(12):828\u2013838","journal-title":"Genes Chromosomes Cancer"},{"key":"2359_CR133","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fonc.2017.00263","volume":"7","author":"MR Corces","year":"2017","unstructured":"Corces MR, Chang HY, Majeti R (2017) Preleukemic hematopoietic stem cells in human acute myeloid leukemia. Front Oncol 7:263","journal-title":"Front Oncol"},{"issue":"4","key":"2359_CR134","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/j.1476-5381.2010.01100.x","volume":"162","author":"H Sill","year":"2011","unstructured":"Sill H et al (2011) Therapy-related myeloid neoplasms: pathobiology and clinical characteristics. Br J Pharmacol 162(4):792\u2013805","journal-title":"Br J Pharmacol"},{"issue":"4","key":"2359_CR135","first-page":"328","volume":"11","author":"FA Lagunas-Rangel","year":"2017","unstructured":"Lagunas-Rangel FA et al (2017) Acute myeloid leukemia-genetic alterations and their clinical prognosis. Int J Hematol Oncol Stem Cell Res 11(4):328\u2013339","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"4","key":"2359_CR136","first-page":"167","volume":"69","author":"HJ de Jonge","year":"2011","unstructured":"de Jonge HJ, Huls G, de Bont ES (2011) Gene expression profiling in acute myeloid leukaemia. Neth J Med 69(4):167\u2013176","journal-title":"Neth J Med"},{"issue":"4","key":"2359_CR137","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H Dohner","year":"2017","unstructured":"Dohner H et al (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129(4):424\u2013447","journal-title":"Blood"},{"issue":"1","key":"2359_CR138","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/bjh.12559","volume":"164","author":"N Shiba","year":"2014","unstructured":"Shiba N et al (2014) Mutations of the GATA2 and CEBPA genes in paediatric acute myeloid leukaemia. Br J Haematol 164(1):142\u2013145","journal-title":"Br J Haematol"},{"issue":"2","key":"2359_CR139","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cell.2014.02.019","volume":"157","author":"S Groschel","year":"2014","unstructured":"Groschel S et al (2014) A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia. Cell 157(2):369\u2013381","journal-title":"Cell"},{"issue":"4","key":"2359_CR140","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ccr.2014.02.008","volume":"25","author":"H Yamazaki","year":"2014","unstructured":"Yamazaki H et al (2014) A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression. Cancer Cell 25(4):415\u2013427","journal-title":"Cancer Cell"},{"issue":"11","key":"2359_CR141","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1038\/leu.2016.185","volume":"30","author":"F Theis","year":"2016","unstructured":"Theis F et al (2016) Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group. Leukemia 30(11):2248\u20132250","journal-title":"Leukemia"},{"issue":"4","key":"2359_CR142","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1521-6926(04)00073-8","volume":"17","author":"GJ Mufti","year":"2004","unstructured":"Mufti GJ (2004) Pathobiology, classification, and diagnosis of myelodysplastic syndrome. Best Pract Res Clin Haematol 17(4):543\u2013557","journal-title":"Best Pract Res Clin Haematol"},{"issue":"1\u20132","key":"2359_CR143","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cbi.2009.10.009","volume":"184","author":"JW Vardiman","year":"2010","unstructured":"Vardiman JW (2010) The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms. Chem Biol Interact 184(1\u20132):16\u201320","journal-title":"Chem Biol Interact"},{"issue":"5","key":"2359_CR144","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937\u2013951","journal-title":"Blood"},{"issue":"2","key":"2359_CR145","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1365-2141.2011.08724.x","volume":"154","author":"H Hasle","year":"2011","unstructured":"Hasle H, Niemeyer CM (2011) Advances in the prognostication and management of advanced MDS in children. Br J Haematol 154(2):185\u2013195","journal-title":"Br J Haematol"},{"issue":"19","key":"2359_CR146","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1182\/blood-2010-04-280313","volume":"116","author":"G Gohring","year":"2010","unstructured":"Gohring G et al (2010) Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome. Blood 116(19):3766\u20133769","journal-title":"Blood"},{"key":"2359_CR147","doi-asserted-by":"crossref","unstructured":"Wlodarski MW et al (2016) Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood 127(11):387\u20131397; quiz 1518","DOI":"10.1182\/blood-2016-01-695775"},{"key":"2359_CR148","unstructured":"Howlader N, Krapcho NA, Miller M, Bishop D, Kosary K, Yu CL, Ruhl M, Tatalovich J, Mariotto Z, Lewis A, Chen DR, Feuer HS, Cronin EJ (eds) (2017, April) SEER Cancer Stat Rev 1975\u20132014. National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/csr\/1975_2014\/. based on November 2016 SEER data submission, posted to the SEER web site"},{"key":"2359_CR149","doi-asserted-by":"crossref","unstructured":"Xu H et al (2013) Novel susceptibility variants at 10p12.31\u201312.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst 105(10):733\u201342","DOI":"10.1093\/jnci\/djt229"},{"issue":"2","key":"2359_CR150","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1182\/blood-2014-12-575688","volume":"126","author":"R Somasundaram","year":"2015","unstructured":"Somasundaram R et al (2015) Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia. Blood 126(2):144\u2013152","journal-title":"Blood"},{"issue":"9","key":"2359_CR151","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","volume":"129","author":"T Girardi","year":"2017","unstructured":"Girardi T et al (2017) The genetics and molecular biology of T-ALL. Blood 129(9):1113\u20131123","journal-title":"Blood"},{"issue":"4","key":"2359_CR152","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1182\/blood.V82.4.1071.1071","volume":"82","author":"M Leonard","year":"1993","unstructured":"Leonard M et al (1993) Dynamics of GATA transcription factor expression during erythroid differentiation. Blood 82(4):1071\u20131079","journal-title":"Blood"},{"key":"2359_CR153","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.795529","volume":"9","author":"H Wang","year":"2021","unstructured":"Wang H et al (2021) Aberrant GATA2 activation in pediatric B-cell acute lymphoblastic leukemia. Front Pediatr 9:795529","journal-title":"Front Pediatr"},{"issue":"1","key":"2359_CR154","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrurol.2016.225","volume":"14","author":"V Rodriguez-Bravo","year":"2017","unstructured":"Rodriguez-Bravo V et al (2017) The role of GATA2 in lethal prostate cancer aggressiveness. Nat Rev Urol 14(1):38\u201348","journal-title":"Nat Rev Urol"},{"issue":"1","key":"2359_CR155","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1530\/ERC-21-0085","volume":"29","author":"S Kaochar","year":"2021","unstructured":"Kaochar S et al (2021) Inhibition of GATA2 in prostate cancer by a clinically available small molecule. Endocr Relat Cancer 29(1):15\u201331","journal-title":"Endocr Relat Cancer"},{"issue":"12","key":"2359_CR156","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1158\/0008-5472.CAN-19-3447","volume":"80","author":"W Hankey","year":"2020","unstructured":"Hankey W, Chen Z, Wang Q (2020) Shaping chromatin states in prostate cancer by pioneer transcription factors. Cancer Res 80(12):2427\u20132436","journal-title":"Cancer Res"},{"issue":"3","key":"2359_CR157","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.molcel.2007.05.041","volume":"27","author":"Q Wang","year":"2007","unstructured":"Wang Q et al (2007) A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol Cell 27(3):380\u2013392","journal-title":"Mol Cell"},{"issue":"2","key":"2359_CR158","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ccell.2014.11.013","volume":"27","author":"SJ Vidal","year":"2015","unstructured":"Vidal SJ et al (2015) A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer. Cancer Cell 27(2):223\u2013239","journal-title":"Cancer Cell"},{"issue":"2","key":"2359_CR159","doi-asserted-by":"publisher","first-page":"451","DOI":"10.18632\/oncotarget.1296","volume":"5","author":"YT Chiang","year":"2014","unstructured":"Chiang YT et al (2014) GATA2 as a potential metastasis-driving gene in prostate cancer. Oncotarget 5(2):451\u2013461","journal-title":"Oncotarget"},{"issue":"51","key":"2359_CR160","doi-asserted-by":"publisher","first-page":"18261","DOI":"10.1073\/pnas.1421415111","volume":"111","author":"B He","year":"2014","unstructured":"He B et al (2014) GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex. Proc Natl Acad Sci USA 111(51):18261\u201318266","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2359_CR161","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cell.2009.04.056","volume":"138","author":"Q Wang","year":"2009","unstructured":"Wang Q et al (2009) Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 138(2):245\u2013256","journal-title":"Cell"},{"issue":"4","key":"2359_CR162","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12032-015-0522-1","volume":"32","author":"Z Wang","year":"2015","unstructured":"Wang Z et al (2015) GATA2 promotes glioma progression through EGFR\/ERK\/Elk-1 pathway. Med Oncol 32(4):87","journal-title":"Med Oncol"},{"issue":"3","key":"2359_CR163","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/hmg\/ddr491","volume":"21","author":"Y Wang","year":"2012","unstructured":"Wang Y et al (2012) GATA2 negatively regulates PTEN by preventing nuclear translocation of androgen receptor and by androgen-independent suppression of PTEN transcription in breast cancer. Hum Mol Genet 21(3):569\u2013576","journal-title":"Hum Mol Genet"},{"issue":"42","key":"2359_CR164","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1038\/onc.2011.144","volume":"30","author":"Y Wang","year":"2011","unstructured":"Wang Y et al (2011) Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers. Oncogene 30(42):4327\u20134338","journal-title":"Oncogene"},{"issue":"4","key":"2359_CR165","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jmb.2005.09.009","volume":"353","author":"K Masuda","year":"2005","unstructured":"Masuda K et al (2005) Androgen receptor binding sites identified by a GREF_GATA model. J Mol Biol 353(4):763\u2013771","journal-title":"J Mol Biol"},{"issue":"2","key":"2359_CR166","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3906\/biy-2010-39","volume":"45","author":"OF Erceylan","year":"2021","unstructured":"Erceylan OF, Savas A, Gov E (2021) Targeting the tumor stroma: integrative analysis reveal GATA2 and TORYAIP1 as novel prognostic targets in breast and ovarian cancer. Turk J Biol 45(2):127\u2013137","journal-title":"Turk J Biol"},{"issue":"10","key":"2359_CR167","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s00277-017-3076-9","volume":"96","author":"WS Hamadou","year":"2017","unstructured":"Hamadou WS et al (2017) GATA2 gene analysis in several forms of hematological malignancies including familial aggregations. Ann Hematol 96(10):1635\u20131639","journal-title":"Ann Hematol"},{"issue":"8","key":"2359_CR168","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/onc.2017.397","volume":"37","author":"SH Song","year":"2018","unstructured":"Song SH et al (2018) Aberrant GATA2 epigenetic dysregulation induces a GATA2\/GATA6 switch in human gastric cancer. Oncogene 37(8):993\u20131004","journal-title":"Oncogene"},{"key":"2359_CR169","doi-asserted-by":"crossref","unstructured":"Cao T et al (2022) A CGA\/EGFR\/GATA2 positive feedback circuit confers chemoresistance in gastric cancer. J Clin Invest 132(6)","DOI":"10.1172\/JCI154074"},{"issue":"3","key":"2359_CR170","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3892\/or.2016.4961","volume":"36","author":"K Xu","year":"2016","unstructured":"Xu K et al (2016) GATA binding protein 2 overexpression is associated with poor prognosis in KRAS mutant colorectal cancer. Oncol Rep 36(3):1672\u20131678","journal-title":"Oncol Rep"},{"issue":"8","key":"2359_CR171","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136020","volume":"10","author":"X Liu","year":"2015","unstructured":"Liu X et al (2015) GATA2 rs2335052 Polymorphism predicts the survival of patients with colorectal cancer. PLoS ONE 10(8):e0136020","journal-title":"PLoS ONE"},{"issue":"1","key":"2359_CR172","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12967-022-03483-8","volume":"20","author":"Y Pan","year":"2022","unstructured":"Pan Y et al (2022) A feedback loop between GATA2-AS1 and GATA2 promotes colorectal cancer cell proliferation, invasion, epithelial-mesenchymal transition and stemness via recruiting DDX3X. J Transl Med 20(1):287","journal-title":"J Transl Med"},{"issue":"2","key":"2359_CR173","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11523-014-0335-8","volume":"10","author":"I Peters","year":"2015","unstructured":"Peters I et al (2015) Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma. Target Oncol 10(2):267\u2013275","journal-title":"Target Oncol"},{"issue":"1","key":"2359_CR174","doi-asserted-by":"publisher","first-page":"9027","DOI":"10.1038\/s41598-020-65915-z","volume":"10","author":"Y Fu","year":"2020","unstructured":"Fu Y et al (2020) GATA2 Regulates constitutive PD-L1 and PD-L2 expression in brain tumors. Sci Rep 10(1):9027","journal-title":"Sci Rep"},{"issue":"1","key":"2359_CR175","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13048-022-00974-6","volume":"15","author":"Q Zhou","year":"2022","unstructured":"Zhou Q et al (2022) Distinct expression and prognostic values of GATA transcription factor family in human ovarian cancer. J Ovarian Res 15(1):49","journal-title":"J Ovarian Res"},{"issue":"8","key":"2359_CR176","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1128\/IAI.68.8.4720-4724.2000","volume":"68","author":"X Tang","year":"2000","unstructured":"Tang X et al (2000) Down-regulation of GATA-2 transcription during Pneumocystis carinii infection. Infect Immun 68(8):4720\u20134724","journal-title":"Infect Immun"},{"key":"2359_CR177","doi-asserted-by":"crossref","unstructured":"Shoger KE et al (2021) CISH attenuates homeostatic cytokine signaling to promote lung-specific macrophage programming and function. Sci Signal 14(698):eabe5137","DOI":"10.1126\/scisignal.abe5137"},{"key":"2359_CR178","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12890-015-0006-2","volume":"15","author":"T Svobodova","year":"2015","unstructured":"Svobodova T et al (2015) Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood. BMC Pulm Med 15:8","journal-title":"BMC Pulm Med"},{"issue":"4","key":"2359_CR179","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.chest.2021.05.046","volume":"160","author":"BE Marciano","year":"2021","unstructured":"Marciano BE et al (2021) Pulmonary manifestations of GATA2 deficiency. Chest 160(4):1350\u20131359","journal-title":"Chest"},{"issue":"6","key":"2359_CR180","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/JTO.0000000000000165","volume":"9","author":"M Tessema","year":"2014","unstructured":"Tessema M et al (2014) GATA2 is epigenetically repressed in human and mouse lung tumors and is not requisite for survival of KRAS mutant lung cancer. J Thorac Oncol 9(6):784\u2013793","journal-title":"J Thorac Oncol"},{"issue":"6","key":"2359_CR181","doi-asserted-by":"publisher","first-page":"954","DOI":"10.4149\/neo_2019_190210N112","volume":"66","author":"L Zhang","year":"2019","unstructured":"Zhang L et al (2019) A MYC target long non-coding RNA GATA2-AS1 regulates non-small cell lung cancer growth. Neoplasma 66(6):954\u2013962","journal-title":"Neoplasma"},{"issue":"13","key":"2359_CR182","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.7150\/jca.52623","volume":"12","author":"C Gong","year":"2021","unstructured":"Gong C et al (2021) Comprehensive analysis of expression and prognostic value of GATAs in lung cancer. J Cancer 12(13):3862\u20133876","journal-title":"J Cancer"},{"issue":"3","key":"2359_CR183","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3724\/abbs.2022005","volume":"54","author":"Y Zhang","year":"2022","unstructured":"Zhang Y et al (2022) LINC00891 regulated by miR-128-3p\/GATA2 axis impedes lung cancer cell proliferation, invasion and EMT by inhibiting RhoA pathway. Acta Biochim Biophys Sin (Shanghai) 54(3):378\u2013387","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"3","key":"2359_CR184","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.cell.2012.02.059","volume":"149","author":"MS Kumar","year":"2012","unstructured":"Kumar MS et al (2012) The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer. Cell 149(3):642\u2013655","journal-title":"Cell"},{"issue":"8","key":"2359_CR185","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1021\/mp400714z","volume":"11","author":"S Shen","year":"2014","unstructured":"Shen S et al (2014) Cationic lipid-assisted polymeric nanoparticle mediated GATA2 siRNA delivery for synthetic lethal therapy of KRAS mutant non-small-cell lung carcinoma. Mol Pharm 11(8):2612\u20132622","journal-title":"Mol Pharm"},{"issue":"1","key":"2359_CR186","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-019-0066-3","volume":"5","author":"BC Trapnell","year":"2019","unstructured":"Trapnell BC et al (2019) Pulmonary alveolar proteinosis. Nat Rev Dis Primers 5(1):16","journal-title":"Nat Rev Dis Primers"},{"key":"2359_CR187","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.aanat.2016.08.003","volume":"208","author":"W Bernhard","year":"2016","unstructured":"Bernhard W (2016) Lung surfactant: function and composition in the context of development and respiratory physiology. Ann Anat 208:146\u2013150","journal-title":"Ann Anat"},{"key":"2359_CR188","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12890-015-0083-2","volume":"15","author":"M Griese","year":"2015","unstructured":"Griese M et al (2015) GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders. BMC Pulm Med 15:87","journal-title":"BMC Pulm Med"},{"issue":"3","key":"2359_CR189","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.pulmoe.2019.09.008","volume":"26","author":"N China","year":"2020","unstructured":"China N et al (2020) rs1573858 GATA-2 homozygote variant associated with pulmonary alveolar proteinosis, cytopenia and neurologic dysfunction. Pulmonology 26(3):178\u2013180","journal-title":"Pulmonology"},{"issue":"5","key":"2359_CR190","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1183\/13993003.00252-2016","volume":"48","author":"A Ballerie","year":"2016","unstructured":"Ballerie A et al (2016) Association of pulmonary alveolar proteinosis and fibrosis: patient with GATA2 deficiency. Eur Respir J 48(5):1510\u20131514","journal-title":"Eur Respir J"},{"issue":"2","key":"2359_CR191","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.clim.2010.02.017","volume":"135","author":"B Carey","year":"2010","unstructured":"Carey B, Trapnell BC (2010) The molecular basis of pulmonary alveolar proteinosis. Clin Immunol 135(2):223\u2013235","journal-title":"Clin Immunol"},{"key":"2359_CR192","doi-asserted-by":"crossref","unstructured":"Liu Z et al (2019) Fate mapping via Ms4a3-expression history traces monocyte-derived cells. Cell 178(6):1509\u20131525 e19","DOI":"10.1016\/j.cell.2019.08.009"},{"issue":"8","key":"2359_CR193","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072404","volume":"8","author":"TT Wu","year":"2013","unstructured":"Wu TT et al (2013) GATA-2 transduces LPS-induced il-1beta gene expression in macrophages via a toll-like receptor 4\/MD88\/MAPK-dependent mechanism. PLoS ONE 8(8):e72404","journal-title":"PLoS ONE"},{"issue":"9","key":"2359_CR194","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1128\/IAI.71.9.4943-4952.2003","volume":"71","author":"ME Lasbury","year":"2003","unstructured":"Lasbury ME et al (2003) Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts. Infect Immun 71(9):4943\u20134952","journal-title":"Infect Immun"},{"key":"2359_CR195","doi-asserted-by":"crossref","unstructured":"Lasbury ME et al (2001) Effect of the transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts. J Eukaryot Microbiol Suppl:158S-159S","DOI":"10.1111\/j.1550-7408.2001.tb00499.x"},{"issue":"2","key":"2359_CR196","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/bjh.13317","volume":"169","author":"M Collin","year":"2015","unstructured":"Collin M, Dickinson R, Bigley V (2015) Haematopoietic and immune defects associated with GATA2 mutation. Br J Haematol 169(2):173\u2013187","journal-title":"Br J Haematol"},{"key":"2359_CR197","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108522","volume":"218","author":"YF van Lier","year":"2020","unstructured":"van Lier YF et al (2020) Allogeneic hematopoietic cell transplantation in the management of GATA2 deficiency and pulmonary alveolar proteinosis. Clin Immunol 218:108522","journal-title":"Clin Immunol"},{"issue":"5","key":"2359_CR198","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.meegid.2008.05.001","volume":"8","author":"CM Aliouat-Denis","year":"2008","unstructured":"Aliouat-Denis CM et al (2008) Pneumocystis species, co-evolution and pathogenic power. Infect Genet Evol 8(5):708\u2013726","journal-title":"Infect Genet Evol"},{"issue":"4","key":"2359_CR199","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4103\/1817-1737.69106","volume":"5","author":"CM Allen","year":"2010","unstructured":"Allen CM et al (2010) Imaging lung manifestations of HIV\/AIDS. Ann Thorac Med 5(4):201\u2013216","journal-title":"Ann Thorac Med"},{"issue":"3","key":"2359_CR200","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1086\/649868","volume":"50","author":"CA Ponce","year":"2010","unstructured":"Ponce CA et al (2010) Pneumocystis colonization is highly prevalent in the autopsied lungs of the general population. Clin Infect Dis 50(3):347\u2013353","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2359_CR201","first-page":"709","volume":"73","author":"W Chen","year":"1992","unstructured":"Chen W, Mills JW, Harmsen AG (1992) Development and resolution of Pneumocystis carinii pneumonia in severe combined immunodeficient mice: a morphological study of host inflammatory responses. Int J Exp Pathol 73(6):709\u2013720","journal-title":"Int J Exp Pathol"},{"issue":"7","key":"2359_CR202","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1172\/JCI560","volume":"102","author":"H Koziel","year":"1998","unstructured":"Koziel H et al (1998) Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. J Clin Invest 102(7):1332\u20131344","journal-title":"J Clin Invest"},{"key":"2359_CR203","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2180-10-103","volume":"10","author":"BH Cheng","year":"2010","unstructured":"Cheng BH et al (2010) Microarray studies on effects of Pneumocystis carinii infection on global gene expression in alveolar macrophages. BMC Microbiol 10:103","journal-title":"BMC Microbiol"},{"key":"2359_CR204","doi-asserted-by":"crossref","unstructured":"Lasbury ME, Durant PJ, and Lee CH (2001) Bronchoalveolar lavage fluid from Pneumocystis carinii-infected rats inhibits phagocytosis in normal alveolar macrophages. J Eukaryot Microbiol Suppl:163S-164S","DOI":"10.1111\/j.1550-7408.2001.tb00502.x"},{"issue":"11","key":"2359_CR205","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/s41419-020-03151-z","volume":"11","author":"R Angioni","year":"2020","unstructured":"Angioni R et al (2020) Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients. Cell Death Dis 11(11):957","journal-title":"Cell Death Dis"},{"issue":"6","key":"2359_CR206","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1164\/rccm.202005-1583OC","volume":"202","author":"OJ McElvaney","year":"2020","unstructured":"McElvaney OJ et al (2020) Characterization of the inflammatory response to severe COVID-19 illness. Am J Respir Crit Care Med 202(6):812\u2013821","journal-title":"Am J Respir Crit Care Med"},{"key":"2359_CR207","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.781352","volume":"12","author":"C Cioccarelli","year":"2021","unstructured":"Cioccarelli C et al (2021) IL1beta promotes TMPRSS2 expression and SARS-CoV-2 cell entry through the p38 MAPK-GATA2 axis. Front Immunol 12:781352","journal-title":"Front Immunol"},{"key":"2359_CR208","doi-asserted-by":"crossref","unstructured":"Hoffmann M et al (2020) SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271\u2013280 e8","DOI":"10.1016\/j.cell.2020.02.052"},{"issue":"12","key":"2359_CR209","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1210\/me.2013-1098","volume":"27","author":"L Clinckemalie","year":"2013","unstructured":"Clinckemalie L et al (2013) Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response element. Mol Endocrinol 27(12):2028\u20132040","journal-title":"Mol Endocrinol"},{"issue":"9","key":"2359_CR210","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.celrep.2016.07.058","volume":"16","author":"KR Katsumura","year":"2016","unstructured":"Katsumura KR et al (2016) GATA Factor-dependent positive-feedback circuit in acute myeloid leukemia cells. Cell Rep 16(9):2428\u20132441","journal-title":"Cell Rep"},{"key":"2359_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173594","volume":"887","author":"T Islam","year":"2020","unstructured":"Islam T et al (2020) Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19. Eur J Pharmacol 887:173594","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2359_CR212","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.gene.2014.04.064","volume":"544","author":"NP Muiya","year":"2014","unstructured":"Muiya NP et al (2014) A study of the role of GATA2 gene polymorphism in coronary artery disease risk traits. Gene 544(2):152\u2013158","journal-title":"Gene"},{"key":"2359_CR213","doi-asserted-by":"crossref","unstructured":"Brown AJ et al (2000) Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells. Accumulation of oxidized esters in lysosomes. J Lipid Res 41(2):226\u201337","DOI":"10.1016\/S0022-2275(20)32056-3"},{"key":"2359_CR214","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.gdata.2016.06.006","volume":"9","author":"YH Goo","year":"2016","unstructured":"Goo YH, Yechoor VK, Paul A (2016) Transcriptional profiling of foam cells in response to hypercholesterolemia. Genom Data 9:37\u201339","journal-title":"Genom Data"},{"issue":"3","key":"2359_CR215","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1161\/01.ATV.18.3.423","volume":"18","author":"G Kellner-Weibel","year":"1998","unstructured":"Kellner-Weibel G et al (1998) Effects of intracellular free cholesterol accumulation on macrophage viability: a model for foam cell death. Arterioscler Thromb Vasc Biol 18(3):423\u2013431","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2359_CR216","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0022-2275(20)40131-2","volume":"35","author":"RK Tangirala","year":"1994","unstructured":"Tangirala RK et al (1994) Formation of cholesterol monohydrate crystals in macrophage-derived foam cells. J Lipid Res 35(1):93\u2013104","journal-title":"J Lipid Res"},{"key":"2359_CR217","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.594136","volume":"11","author":"C Yin","year":"2020","unstructured":"Yin C et al (2020) Efferocytic defects in early atherosclerosis are driven by GATA2 overexpression in macrophages. Front Immunol 11:594136","journal-title":"Front Immunol"},{"issue":"12","key":"2359_CR218","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1161\/CIRCRESAHA.117.312509","volume":"122","author":"C Cochain","year":"2018","unstructured":"Cochain C et al (2018) Single-cell RNA-Seq reveals the transcriptional landscape and heterogeneity of aortic macrophages in murine atherosclerosis. Circ Res 122(12):1661\u20131674","journal-title":"Circ Res"},{"issue":"2","key":"2359_CR219","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2012.09.013","volume":"225","author":"JL Stoger","year":"2012","unstructured":"Stoger JL et al (2012) Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 225(2):461\u2013468","journal-title":"Atherosclerosis"},{"issue":"3","key":"2359_CR220","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2353\/ajpath.2009.080431","volume":"174","author":"JJ Boyle","year":"2009","unstructured":"Boyle JJ et al (2009) Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am J Pathol 174(3):1097\u20131108","journal-title":"Am J Pathol"},{"issue":"1","key":"2359_CR221","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/CIRCRESAHA.111.247577","volume":"110","author":"JJ Boyle","year":"2012","unstructured":"Boyle JJ et al (2012) Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection. Circ Res 110(1):20\u201333","journal-title":"Circ Res"},{"issue":"6","key":"2359_CR222","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1161\/CIRCRESAHA.109.215715","volume":"107","author":"A Kadl","year":"2010","unstructured":"Kadl A et al (2010) Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ Res 107(6):737\u2013746","journal-title":"Circ Res"},{"key":"2359_CR223","doi-asserted-by":"crossref","unstructured":"Koller D et al (2014) Effects of oxidized phospholipids on gene expression in RAW 264.7 macrophages: a microarray study. PLoS One 9(10):e110486","DOI":"10.1371\/journal.pone.0110486"},{"issue":"11","key":"2359_CR224","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1253\/circj.CJ-16-0924","volume":"80","author":"MF Linton","year":"2016","unstructured":"Linton MF et al (2016) Macrophage apoptosis and efferocytosis in the pathogenesis of atherosclerosis. Circ J 80(11):2259\u20132268","journal-title":"Circ J"},{"issue":"9","key":"2359_CR225","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1002\/eji.201141719","volume":"41","author":"E Thorp","year":"2011","unstructured":"Thorp E, Subramanian M, Tabas I (2011) The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis. Eur J Immunol 41(9):2515\u20132518","journal-title":"Eur J Immunol"},{"issue":"9","key":"2359_CR226","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s10495-010-0516-6","volume":"15","author":"EB Thorp","year":"2010","unstructured":"Thorp EB (2010) Mechanisms of failed apoptotic cell clearance by phagocyte subsets in cardiovascular disease. Apoptosis 15(9):1124\u20131136","journal-title":"Apoptosis"},{"issue":"5","key":"2359_CR227","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1189\/jlb.0209115","volume":"86","author":"E Thorp","year":"2009","unstructured":"Thorp E, Tabas I (2009) Mechanisms and consequences of efferocytosis in advanced atherosclerosis. J Leukoc Biol 86(5):1089\u20131095","journal-title":"J Leukoc Biol"},{"issue":"6","key":"2359_CR228","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","volume":"123","author":"MA Spinner","year":"2014","unstructured":"Spinner MA et al (2014) GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood 123(6):809\u2013821","journal-title":"Blood"},{"issue":"7","key":"2359_CR229","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10815-018-1146-0","volume":"35","author":"JR Zolton","year":"2018","unstructured":"Zolton JR et al (2018) Oocyte cryopreservation for women with GATA2 deficiency. J Assist Reprod Genet 35(7):1201\u20131207","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"2359_CR230","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/ICB.0000000000000558","volume":"13","author":"D Berry","year":"2019","unstructured":"Berry D, Fekrat S (2019) Central retinal vein occlusion in Gata2 deficiency. Retin Cases Brief Rep 13(2):181\u2013184","journal-title":"Retin Cases Brief Rep"},{"issue":"5","key":"2359_CR231","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3324\/haematol.2021.278450","volume":"107","author":"G Purgatorio","year":"2022","unstructured":"Purgatorio G et al (2022) Germline GATA2 variant disrupting endothelial eNOS function and angiogenesis can be restored by c-Jun\/AP-1 upregulation. Haematologica 107(5):1072\u20131085","journal-title":"Haematologica"},{"issue":"5","key":"2359_CR232","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1172\/JCI117557","volume":"94","author":"M Ziche","year":"1994","unstructured":"Ziche M et al (1994) Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94(5):2036\u20132044","journal-title":"J Clin Invest"},{"issue":"3","key":"2359_CR233","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1074\/jbc.272.3.1747","volume":"272","author":"E Noiri","year":"1997","unstructured":"Noiri E et al (1997) Permissive role of nitric oxide in endothelin-induced migration of endothelial cells. J Biol Chem 272(3):1747\u20131752","journal-title":"J Biol Chem"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02359-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-023-02359-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02359-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T07:06:48Z","timestamp":1696662408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-023-02359-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":233,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["2359"],"URL":"https:\/\/doi.org\/10.1007\/s00109-023-02359-8","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,25]]},"assertion":[{"value":"9 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and informed consent"}},{"value":"The authors declare no conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}